1. Home
  2. PDSB vs MCHX Comparison

PDSB vs MCHX Comparison

Compare PDSB & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • MCHX
  • Stock Information
  • Founded
  • PDSB 2005
  • MCHX 2003
  • Country
  • PDSB United States
  • MCHX United States
  • Employees
  • PDSB N/A
  • MCHX N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • PDSB Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • PDSB Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • PDSB 72.2M
  • MCHX 84.3M
  • IPO Year
  • PDSB N/A
  • MCHX 2004
  • Fundamental
  • Price
  • PDSB $1.19
  • MCHX $2.00
  • Analyst Decision
  • PDSB Strong Buy
  • MCHX
  • Analyst Count
  • PDSB 2
  • MCHX 0
  • Target Price
  • PDSB $10.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • PDSB 544.6K
  • MCHX 44.2K
  • Earning Date
  • PDSB 08-12-2025
  • MCHX 08-07-2025
  • Dividend Yield
  • PDSB N/A
  • MCHX N/A
  • EPS Growth
  • PDSB N/A
  • MCHX N/A
  • EPS
  • PDSB N/A
  • MCHX N/A
  • Revenue
  • PDSB N/A
  • MCHX $47,951,000.00
  • Revenue This Year
  • PDSB N/A
  • MCHX $5.77
  • Revenue Next Year
  • PDSB N/A
  • MCHX N/A
  • P/E Ratio
  • PDSB N/A
  • MCHX N/A
  • Revenue Growth
  • PDSB N/A
  • MCHX N/A
  • 52 Week Low
  • PDSB $0.85
  • MCHX $1.26
  • 52 Week High
  • PDSB $4.32
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 39.96
  • MCHX 46.15
  • Support Level
  • PDSB $1.02
  • MCHX $1.95
  • Resistance Level
  • PDSB $1.28
  • MCHX $2.11
  • Average True Range (ATR)
  • PDSB 0.11
  • MCHX 0.09
  • MACD
  • PDSB -0.01
  • MCHX -0.03
  • Stochastic Oscillator
  • PDSB 47.61
  • MCHX 1.22

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: